Earlier this month, Trump administration called on National Institutes of Health (NIH) to impose limits specific types of funding Provides research institutions.
Although a federal judge has temporarily blocked Policy change, government grants to newly established early stage biotechnology companies could be delayed or eliminated entirely, said Chris Gibson, co -founder and chief executive of RECURSION, a biotechnology used by AI.
Gibson, along with a biotechnology serial businessman, David Bearsss, saw the confusion as an opportunity to launch a pre-trader fund, Dubbed Altitude Lab Pre-Speed Venture FundThis will seek to invest $ 100,000 to $ 250,000 in 10 to 15 biotechnology companies.
Gibson said that the newly established businesses with the NIH Small Innovation Grants (SBIR) are invited to apply to the Fund. The fund will manage Wall Lab, a Salt Lake City, a non -profit, Life Sciences accelerator, which was repetition that was created five years ago.
“SBIR subsidies are close and dear in my heart,” Gibson said. “The first thing I did when we started the repetition was to write a SBIR subsidy and got $ 1.46 million from the federal government.”
This 2014 funding helped repetition to create its set of data, which was the basis of the mechanical learning algorithm and the drug discovery platform, Gibson said. Since then the company has raised many rounds of business capital from investors such as Lux Capital, Menlo Ventures and Felicis and has been published in 2021.
Gibson said he hoped that the fund will “fill the gap” for new biotechnologies during this period of uncertainty about NIH funding.
“Early science is extremely dangerous. It is difficult to know how these companies will prove, but companies that are funded by SBIR grants are dramatically more likely to continue to be able to raise private money,” Gibson said.
The fund will also help develop the biotechnology ecosystem next to the repetition. The newly established businesses will receive 12 months of office and laboratory at the Waditude Lab premises.
“We are creating our own mini-Cambridge here on the streets of Salt Lake City,” Gibson said.
